LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis

Prostate

Volumn 44, Issue 2, 2000, Pages 91-103

  Thalmann, George N ^a   Sikes, Robert A ^b   Wu, Tony T ^b   Degeorges, Armelle ^b   Chang, Shi Ming ^b   Ozen, Mustafa ^c   Pathak, Sen ^c   Chung, Leland W K ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Androgen independence; CGH; Chromosomal losses and gains; Cytogenetics; Prostate cancer progression; PSA expression; Skeletal metastasis; Stromal epithelial interaction

Indexed keywords

ANDROGEN;

ANTIGEN EXPRESSION; ARTICLE; BONE METASTASIS; CANCER GROWTH; CELL CULTURE; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALS; BLOTTING, NORTHERN; BONE NEOPLASMS; CELL LINE; DIHYDROTESTOSTERONE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENTIAN VIOLET; HISTOCYTOCHEMISTRY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; KARYOTYPING; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; ORCHIECTOMY; OSTEOSARCOMA; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RNA, NEOPLASM; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR CELLS, CULTURED;

EID: 0034234571     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20000701)44:2<91::AID-PROS1>3.0.CO;2-L     Document Type: Article

References (41)

1. Carter HB, Coffey DS. The prostate: an increasing medical problem. Prostate 1990;16:39-48.
2. Parker SL, Tong T, Bolden BA, Wingo PA. Cancer statistics 1997. CA Cancer J Clin 1997;47:5-27.
3. Gleave ME, Hsieh JT, von Eschenbach AC, Chung LWK. Prostate and fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. J Urol 1992; 147:1151-1159.
4. Chung LWK. Implications of stromal-epithelial interaction in human prostate cancer growth, progression and differentiation. Semin Cancer Biol 1993;4:183-192.
5. Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S, Chung LWK. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer 1994;57:406-492.
6. Thalmann GN, Anezinis PA, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LWK. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 1994; 54:2577-2781.
7. Horoscewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43:1809-1818.
8. Gleave ME, Hsieh JT, Gao C, von Eschenbach AC, Chung LWK. Acceleration of human prostate cancer growth in vivo by prostate and bone fibroblasts. Cancer Res 1991;51:3753-3761.
9. Chang SM, Chung LWK. Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology 1989;125:2719-2727.
10. Janik P, Briand P, Hartman NR. The effect of estroneprogesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res 1975;35:3698-3704.
11. Gillies RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. Anal Biochem 1986;159:103-113.
12. Pathak S. Chromosome banding techniques. J Reprod Med 1976; 17:25-28.
13. Passaniti A, Isaacs JT, Haney JA, Adler SW, Cujdik TJ, Long PV, Kleinman HK. Stimulation of human prostatic carcinoma tumor growth in athymic nude mice and control of migration in culture by extracellular matrix. Int J Cancer 1992;51:318-324.
14. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1986;162:156-159.
15. Scher HI, Chung LWK. Bone metastasis: improving the therapeutic index. Semin Oncol 1994;21:630-656.
16. Sikes RA, Chung LWK. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene. Cancer Res 1992;52:3174-3181.
17. Zhau HYE, Zhou J, Symmans WF, Chen BW, Chang SM. Sikes RA, Chung LWK. Transfected neu oncogene induces human prostate cancer metastasis. Prostate 1996;28:73-83.
18. Marengo SR, Sikes RA, Plutarchos A, Chang SM, Chung LWK. Metastasis induced by overexpression of p185neu-T after orthotopic injection into a prostatic epithelial cell line (NbE). Mol Carcinog 1997;19:165-175.
19. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995;92:3439-3443.
20. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM. Metastatic prostate cancer in a transgenic mouse. Cancer Res 1996; 56:4096-4102.
21. Kasper S, Sheppard PC, Yan Y, Pettigrew N, Borowsky AD, Prins GS, Dodd JG, Duckworth ML, Matusik RJ. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab Invest 1998;78:319-333.
22. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ. Selection of highly metastatic variants of different human prostate carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 1996;2:1627-1636.
23. Lubaroff DM, Canfield L, Reynolds CW. The Dunning tumors. Prog Clin Biol Res 1980;37:243-263.
24. Hyytinen E-R, Thalmann GN, Zhau HE, Karhu R, Kallioniemi O-P, Chung LWK, Visakorpi T. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model. Br J Cancer 1997;75:190-195.
25. Brothman AR, Patel AM, Peehl DM, Schellhammer PF. Analysis of prostatic tumor cultures using fluorescence in-situ hybridization (FISH). Cancer Genet Cytogenet 1992;62:180-185.
26. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer 1992;4:16-24.
27. Micale MA, Mohamed A, Sakr W, Powell IJ, Wolman SR. Cytogenetics of primary prostatic adenocarcinoma. Cancer Genet Cytogenet 1992;61:165-173.
28. König JJ, Kamst E, Hagemeijer A, Romijn JC, Horoszewicz J, Schröder FH. Cytogenetic characterization of androgen-responsive and -unresponsive sublines of the human prostatic carcinoma cell line LNCaP. Urol Res 1989;17:79-86.
29. Carter BS, Ewing CM, Ward SW, Treiger BF, Aalders TW, Schalken JA, Epstein JL, Isaacs WB. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 1990;87:8751-8755.
30. Bergerheim US, Kunimi K, Collins VP, Ekman P. Deletion mapping of chromosomes 8, 10, and 16 in human prostate carcinoma. Genes Chromosomes Cancer 1991;3:215-220.
31. Noble RL. The development of prostatic adenocarcinoma in NB rats following prolonged sex hormone administration. Cancer Res 1977;37:1929-1933.
32. Dunning WF. Prostate cancer in rat. Monogr Natl Cancer Inst 1963;12:351-370.
33. Bruchovsky N, Rennie PS. Classification of dependent and autonomous variants of Shionogi mammary carcinoma based on heterogenous patterns of androgen binding. Cell 1978;13:273-280.
34. Scher HI, Zhang ZF, Nanus D, Kelly WK. Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer. Urology 1996;47:61-69.
35. Umekita Y, Hiipakka RA, Kokontis JM, Liao S. Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride. Proc Natl Acad Sci USA 1996;93: 11802-11807.
36. Zhau HYE, Chang SM, Chen BQ, Wang Y, Zhang H, Kao C, Sang QA, Pathak SJ, Chung LWK. Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci USA 1996; 93:15152-15157.
37. Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, Sullivan LD. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer 1993;71:2782-2790.
38. Batson OV. The role of the vertebral veins and their role in the spread of metastases. Ann Surg 1940;112:138-141.
39. Weiss L, Haydock K, Pickren JW, Lane WW. Organ vascularity and metastatic frequency. Am J Pathol 1980;101:101-114.
40. Stephenson RA, Dinney CPN, Gohji K, Ordonez NG, Killion JJ, Fidler IJ. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 1992;84: 951-957.
41. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-573.